Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-20

Clinical Trial Update: Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer

View source ↗

Summary

Ongoing ClinicalTrials.gov study investigating the genetic causes and cancer predisposition in hereditary leiomyomatosis with renal cell carcinoma; recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Renal Tumor Histology, Cutaneous Leiomyoma | Status: RECRUITING